SPECIAL REPORT: EVAR IN HIGH-RISK PATIENTS
Gregorio A. Sicard, MD, explains the origin of the SVS Outcomes Committee and its current initiatives, including examination of high-risk patient data from the US IDE endovascular aneurysm repair trials.
By Gregorio A. Sicard, MD
Professor Roger Greenhalgh, Professor Janet Powell, and Louise Brown address outside interpretations of the design and conclusions of the EVAR-2 trial.
By Professor Roger Greenhalgh, Professor Janet Powell, and Louise Brown
Rodney A. White, MD, discusses the goals of the SVS Outcomes Committee, issues in reimbursement, and assessments of high-risk patient outcomes data.
By Rodney A. White, MD
K. Craig Kent, MD, describes the advantages and disadvantages of each of the available datasets on endovascular repair in high-risk patients, including what has been learned from the extensive Medicare database.
By K. Craig Kent, MD
Roy K. Greenberg, MD, explains the Cleveland Clinic's experiences with high-risk aneurysm patients, the limitations of current comparative analyses, and the search for predictors of mortality.
By Roy K. Greenberg, MD
Robert Zwolak, MD, discusses his work with the SVS Outcomes Committee, the role of AHRQ, and his perspective on contemporary endovascular aneurysm trials.
By Robert Zwolak, MD
Dorothy B. Abel discusses the FDA's considerations and its role regarding trial data.
By Dorothy B. Abel
A panel of interventional radiologists discusses the issues and controversies surrounding hemodialysis, and the use of catheters, fistulae, and grafts as access.
By Abigail Falk, MD; Ziv Haskal, MD; Matthew S. Johnson, MD; Gordon McLennan, MD; and Tom Vesely, MD
Patient selection, choice of devices, and guidelines for avoiding complications in successful carotid stent placement.
By Mark H. Wholey, MD
Lessons learned from 246 carotid artery stenting procedures.
By Peter H. Lin, MD; Wei Zhou, MD; Panos Kougias, MD; Hosam El Sayed, MD; and Alan B. Lumsden, MD
A review of the data regarding the theoretical advantages of embolic protection devices over unprotected CAS procedures.
By James A.M. Smith, DO
An overview of the characteristics, detection methods, and response to treatment of vulnerable plaque in the carotids
By Emile R. Mohler III, MD
The "double-wire" technique is an effective method of treating these complex lesions.
By James Joye, DO
Is carotid plaque morphology ready for prime time?
By Brajesh K. Lal, MD, and Robert W. Hobson II, MD
New endpoints and new data have made TACIT even more critical.
By Endovascular Today interviews John H. Rundback, MD
EVT's Chief Interventional Cardiologist discusses his move to UC Davis, his most rewarding procedures, and VIVA 2006.